Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;197(5):558-572.
doi: 10.1111/bjh.18083. Epub 2022 Feb 22.

Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline

George A Follows  1 , Sally F Barrington  2 , Kaljit S Bhuller  3 , Dominic J Culligan  4 , David J Cutter  5 , Eve Gallop-Evans  6 , Shireen Kassam  7 , Wendy Osborne  8 , Shalal Sadullah  9 , William Townsend  10 , Benjamin J Uttenthal  1 , Graham P Collins  11 ; British Society for Haematology
Affiliations
Review

Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline

George A Follows et al. Br J Haematol. 2022 Jun.

Abstract

This guideline was compiled according to the British Society for Haematology (BSH) process at BSH Guidelines Process 2016 (b-s-h.org.uk). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) nomenclature was used to evaluate levels of evidence and to assess the strength of recommendations. The GRADE criteria can be found at http://www.gradeworkinggroup.org. Recommendations are based on a review of the literature using Medline, PubMed/Medline and Cochrane searches beginning from 2013 up to January 2021. The following search terms were used: [Hodgkin lymphoma OR Hodgkin disease] NOT non-Hodgkin; AND [chemotherapy OR radiotherapy]; AND [elderly]; AND [teenage OR adolescent OR young adult]; AND [pregnancy]. Filters were applied to include only publications written in English, studies carried out in humans, clinical conferences, congresses, clinical trials, clinical studies, meta-analyses, multicentre studies and randomised controlled trials. References pre-2013 were taken from the previous version of this guideline.1 Review of the manuscript was performed by the British Society for Haematology (BSH) Guidelines Committee Haematology Oncology Taskforce, the BSH Guidelines Committee and the Haematology Oncology sounding board of BSH.

Keywords: Hodgkin; Hodgkin's lymphoma; chemotherapy; radiotherapy; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Follows GA, Ardeshna KM, Barrington SF, Culligan DJ, Hoskin PJ, Linch D, et al. Guidelines for the first line management of classical Hodgkin lymphoma. Br J Haematol. 2014;166(1):34-49.
    1. El-Galaly TC, D'Amore F, Mylam KJ, de Nully BP, Bøgsted M, Bukh A, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol. 2012;30(36):4508-14.
    1. Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, et al. PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study. Blood. 2016;127(12):1531-8.
    1. Voltin C-A, Goergen H, Baues C, Fuchs M, Mettler J, Kreissl S, et al. Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin study group trials HD16, HD17, and HD18. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(9):1926-31.
    1. Mikhaeel NG, Milgrom SA, Terezakis S, Berthelsen AK, Hodgson D, Eich HT, et al. The optimal use of imaging in radiation therapy for lymphoma: guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2019;104(3):501-12.

LinkOut - more resources